The cornerstone of Cell>Point is metabolic imaging and therapeutic targeting through nuclear medicine. The company is developing novel radiopharmaceutical imaging agents, radio-therapeutic agents and local regional radio/chemotherapeutic drug delivery systems for the dia ... more 

Our pipeline includes more than 15 molecular imaging and therapeutic agents in addition to local regional chemotherapy and radiotherapy using In Situ Hydrogel ... more

Cell>Point has entered into long-term commitments to financially sponsor and support continuing research and development at M. D. Ander ... more